Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients

被引：0
|
作者：
Azam Taghinejad
Shaghik Barani
Naser Gholijani
Farzad Ghandehari
Soolmaz Khansalar
Morvarid Asadipour
Mohammadali Davarpanah
Mohammadreza Fattahi
Kurosh Kalantar
机构：
[1] Shiraz University of Medical Sciences,Gastroenterology Research Center
[2] Shiraz University of Medical Sciences,Department of Immunology, Shiraz Medical School
[3] Shiraz University of Medical Sciences,Autoimmune Diseases Research Center
[4] Shiraz University of Medical Sciences,Shiraz HIV/AIDS Research Center, Institute of Health
来源：
European Cytokine Network | 2020年 / 31卷
关键词：
Hepatitis C virus; IL-35; IL-22; IL-27; liver enzymes; sofosbuvir; daclatasvir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：134 / 139
页数：5
相关论文
共 50 条
  • [1] Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients
    Taghinejad, Azam
    Barani, Shaghik
    Gholijani, Naser
    Ghandehari, Farzad
    Khansalar, Soolmaz
    Asadipour, Morvarid
    Davarpanah, Mohammadali
    Fattahi, Mohammadreza
    Kalantar, Kurosh
    [J]. EUROPEAN CYTOKINE NETWORK, 2020, 31 (04) : 134 - 139
  • [2] IL-27 and IL-35 as gene therapy of neuroinflammation
    Casella, Giacomo
    Finardi, Annamaria
    Furlan, Roberto
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 215 - 215
  • [3] THE ROLE OF THE CYTOKINES IL-27 AND IL-35 IN CANCER
    Friedman, Avner
    Liao, Kang-Ling
    [J]. MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2015, 12 (06) : 1203 - 1217
  • [4] IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
    Kourko, Olena
    Seaver, Kyle
    Odoardi, Natalya
    Basta, Sameh
    Gee, Katrina
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [5] Decreased serum levels of IL-27and IL-35 in patients with Graves disease
    Saeed, Malek-Hosseini
    Kurosh, Kalantar
    Zahra, Amirghofran
    Hossein, Dabbaghmanesh Mohamad
    Davood, Rostamzadeh
    Ataollahi, Mohammad Reza
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2020, 64 (05): : 521 - 527
  • [6] Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders
    Zhang, Da-Qi
    Jia, Kun
    Wang, Rong
    Li, Ting
    Zhao, Ning
    Yang, Li-Na
    Yang, Li
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2016, 293 : 100 - 104
  • [7] Serum IL-27, IL-23 and IL-35 Levels in Neuromyelitis Optica Spectrum Disorders with Aquaporin-4 and Multiple Sclerosis
    Idiman, Egemen
    Kaya, D.
    Hasankoyoglu, O.
    Keskin, A. O.
    Tasdemir, N.
    Altun, Z.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 409 - 409
  • [8] Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis
    Sobhan, Mohammad Reza
    Farshchian, Mahmood
    Hoseinzadeh, Ali
    Ghasemibasir, Hamid Reza
    Solgi, Ghasem
    [J]. IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (04) : 317 - 323
  • [9] The effects of IL-27 and IL-35 gene variation and expression levels on the susceptibility and clinical manifestations of pulmonary tuberculosis
    Gao, Lei
    Xiong, Yan-Jun
    Liang, Ya-Xue
    Huang, Peng-Fei
    Liu, Shuang
    Xiao, Yu
    Huang, Qian
    Wang, Hua
    Wu, Hui-Mei
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
    Casella, Giacomo
    Finardi, Annamaria
    Descamps, Helene
    Colombo, Federico
    Maiorino, Chiara
    Ruffini, Francesca
    Patrone, Marco
    Degano, Massimo
    Martino, Gianvito
    Muzio, Luca
    Becher, Burkhard
    Furlan, Roberto
    [J]. SCIENTIFIC REPORTS, 2017, 7
12345